儿童喘和家庭中的菌-A元分析
Marton Kristof Varga1, Hanns Moshammer2,3, Oral Atanyazova4
1ZPH, Department of Environmental Health, Medical University of Vienna, ZPH, Kinderspitalgasse 15, 1090, Vienna, Austria.
Wiener klinische Wochenschrift
|July 11, 2024
概括
生活在有菌的家庭中显著增加了儿童患喘的风险. 这一系统性审查证实,菌暴露是儿童喘发展的关键因素.
科学领域:
- 环境健康 环境健康
- 儿科呼吸系统医学 儿科呼吸系统医学
- 流行病学 流行病学
背景情况:
- 儿童喘是一种复杂的疾病,受遗传和环境因素的影响.
- 家庭中的菌已知是患有喘的儿童喘发作的触发因素.
- 菌在儿童喘初期发展中的作用尚不清楚.
研究的目的:
- 系统地审查和元分析队列和病例控制研究.
- 调查家庭菌暴露和儿童喘发展之间的因果关系.
主要方法:
- 进行了系统性审查和随机效应元分析.
- 包括21个病例控制和11个对家庭菌和儿童喘的队列研究.
- 分析数据以评估与成的房屋相关的喘风险.
主要成果:
- 病例控制研究表明,成的房屋中喘风险增加了53% (CI: 42-65%).
- 队列研究显示较小,但显著的15%的风险增加 (CI:1-31%).
- 没有发现出版偏差,但队列研究显示异质性.
结论:
- 儿童暴露在家中的菌与患喘的风险增加有关.
- 进一步的研究可能会澄清具体的机制和促成因素.
- 针对室内菌的环境干预措施可能对预防喘至关重要.
相关概念视频
Asthma-I: Introduction
2.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
Asthma-II: Pathophysiology and Classification
2.6K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.6K
Asthma: Pathogenesis and Management
381
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
381
Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
Asthma-III: Symptoms and Complications
2.5K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
2.5K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
267
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
267


